Gutmann D H, Boguski M, Marchuk D, Wigler M, Collins F S, Ballester R
The Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Oncogene. 1993 Mar;8(3):761-9.
The gene for von Recklinghausen neurofibromatosis type 1 (NF1) was recently identified by positional cloning and found to encode a protein with sequence similarity to a family of eucaryotic GTPase-activating proteins (GAPs). Expression of the NF1-GAP-related domain (NF1GRD) has been shown to complement yeast strains deficient in the yeast GAP homologs, IRA1 and IRA2, to interact with human RAS proteins and to accelerate the conversion of ras-GTP to ras-GDP. Further analysis of this region has revealed a number of residues that are highly conserved between members of the GAP family. Mutational analysis of a representative number of these residues produced one of three effects: (1) no change in NF1GRD function, (2) complete disruption of NF1GRD function and (3) intermediate retention of NF1GRD function. One of these mutations at residue 1423 was shown to have reduced ability to negatively regulate ras in yeast, which is interesting in light of a recent report demonstrating a similar naturally occurring mutation in human malignancies.
1型冯雷克林霍增氏神经纤维瘤病(NF1)基因最近通过定位克隆得以鉴定,发现其编码的一种蛋白质与真核生物GTP酶激活蛋白(GAP)家族具有序列相似性。已证明NF1-GAP相关结构域(NF1GRD)的表达可补充酵母GAP同源物IRA1和IRA2缺陷的酵母菌株,能与人RAS蛋白相互作用,并加速ras-GTP向ras-GDP的转化。对该区域的进一步分析揭示了GAP家族成员之间一些高度保守的残基。对这些残基中具有代表性的数量进行突变分析产生了三种效应之一:(1)NF1GRD功能无变化;(2)NF1GRD功能完全破坏;(3)NF1GRD功能部分保留。其中位于1423位残基的一个突变显示出在酵母中负调控ras的能力降低,鉴于最近一份报告表明人类恶性肿瘤中存在类似的自然发生突变,这一点很有意思。